Adrenal Cancer Diagnostics Market Report 2026

Adrenal Cancer Diagnostics Market Overview

• Adrenal Cancer Diagnostics market size has reached to $148.54 billion in 2025 • Expected to grow to $206.14 billion in 2030 at a compound annual growth rate (CAGR) of 7% • Growth Driver: Rising Cigarette Smoking Boost The Adrenal Cancer • Market Trend: Accelerator Launched To Advance Digital Innovations And Collaboration In Oncology • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Adrenal Cancer Diagnostics Market?

Adrenal cancer diagnostics refers to the process of identifying and diagnosing adrenal cancer, which is cancer that originates in the adrenal glands located above the kidneys. This process involves a series of medical evaluations, tests, and procedures designed to determine whether a person has adrenal cancer. It is essential for effective treatment planning and management. The main tests of adrenal cancer diagnostics are magnetic resonance imaging (MRI), computed tomography (CT) scan, X-ray, positron emission tomography (PET) scan, and biopsy. Magnetic resonance imaging (MRI) refers to a medical imaging technique that uses strong magnetic fields and radio waves to create detailed and high-resolution images of the internal structures of the body. The treatment involves surgery, chemotherapy, radiotherapy, targeted cancer therapies, and others for pheochromocytoma, adrenal cortical carcinoma, and other tumor types done by various end-users such as hospitals, ambulatory surgical centers, cancer centers, and others.

What Is The Adrenal Cancer Diagnostics Market Growth Forecast?

The adrenal cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $206.14 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to advancement in contrast-enhanced imaging technologies, growth in targeted adrenal cancer therapies, rising adoption of pet-ct combination scans, expansion of specialized cancer centers, increasing government funding for cancer diagnostics. Major trends in the forecast period include rising adoption of advanced imaging techniques for adrenal cancer, increasing use of minimally invasive biopsy procedures, growth in targeted cancer therapy applications, expansion of multidisciplinary cancer diagnostic centers, enhanced focus on early detection and personalized treatment.

Global Adrenal Cancer Diagnostics Market Segmentation

1) By Test: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Positron Emission Tomography (PET) Scan, Biopsy 2) By Tumor Type: Pheochromocytoma, Adrenal Cortical Carcinoma, Other Tumor Types 3) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Centers, Other End-Users Subsegments: 1) By Magnetic Resonance Imaging (MRI): Contrast-Enhanced MRI, Functional MRI 2) By Computed Tomography (CT) Scan: Contrast-Enhanced CT, Abdomen And Pelvis CT Scans 3) By Positron Emission Tomography (PET) Scan: PET-CT Combination Scans, Standalone PET Scans 4) By Biopsy: Fine Needle Aspiration Biopsy (FNA), Core Needle Biopsy, Surgical Biopsy

What Is The Driver Of The Adrenal Cancer Diagnostics Market?

The rising cigarette smoking is expected to propel the growth of the adrenal cancer diagnostics market going forward. Cigarette smoking refers to the act of inhaling and exhaling the fumes of burning tobacco, which contains nicotine, an addictive alkaloid that can have both stimulating and tranquilizing psychoactive effects. Cigarette smoking has been associated with an increased risk of adrenal cancer, including adrenal adenomas and adrenocortical carcinomas. The carcinogens in tobacco smoke can damage the DNA in adrenal cells, leading to mutations that can cause cancer. For instance, in August 2024, according to Statistics Canada, a Canada-based government agency, in July 2024, Canadian manufacturers produced 1.2 billion cigarettes, marking a 4.3% increase from June 2024 and a 2.3% rise compared to July 2023. Therefore, the rising cigarette smoking is driving the growth of the adrenal cancer diagnostics industry.

Key Players In The Global Adrenal Cancer Diagnostics Market

Major companies operating in the adrenal cancer diagnostics market are Johnson And Johnson Pvt Ltd., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson and Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies, Hologic Inc., PerkinElmer Inc., Illumina Inc., Roche Diagnostics, BioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Exact Sciences Corp., Natera Inc., Invitae Corporation, Qiagen NV, Guardant Health Inc., Foundation Medicine Inc., NanoString Technologies Inc.

Global Adrenal Cancer Diagnostics Market Trends and Insights

Major companies operating in the adrenal cancer diagnostics market are developing innovative initiatives with advanced collaboration models, such as the CancerX Startup Accelerator, to enhance digital innovations in cancer care. The Accelerator aims to provide promising startups with mentorship, training, and direct access to key players in the healthcare industry, including providers and pharmaceutical companies. For instance, in November 2023, CanceRx, LLC, a US-based public-private partnership to boost innovation in the fight against cancer, announced the launch of this initiative at the Future of Cancer Care Summit in Tampa, Florida. The program will select its inaugural cohort of approximately 15 to 20 companies starting in March 2024, focusing on critical themes like clinical research, screening, diagnosis, and treatment. It is expected to significantly advance the goals of the Cancer Moonshot initiative by addressing unmet needs in cancer care and fostering the development of effective digital health tools in oncology.

What Are Latest Mergers And Acquisitions In The Adrenal Cancer Diagnostics Market?

In June 2023 Quest Diagnostics a US-based Medical laboratories company acquired Haystack Oncology, Inc. for an undisclosed amount. Following this acquisition, Quest Diagnostics will incorporate Haystack Oncology’s minimal-residual disease (MRD) testing technology which is based on circulating tumor DNA (ctDNA). Haystack Oncology Inc. is a US-based Biotechnology Company.

Regional Outlook

North America was the largest region in the adrenal cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Adrenal Cancer Diagnostics Market?

The adrenal cancer diagnostics market consists of revenues earned by entities by providing genetic testing, histopathology, blood tests, and dexamethasone suppression tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The adrenal cancer diagnostics market also includes sales of ultrasound machines, reagents and test kits, microscopes, histology kits, and microtomes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Adrenal Cancer Diagnostics Market Report 2026?

The adrenal cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the adrenal cancer diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.